W.G. Shaheen & Associates Dba Whitney & CO Eli Lilly & CO Transaction History
W.G. Shaheen & Associates Dba Whitney & CO
- $963 Million
- Q2 2025
A detailed history of W.G. Shaheen & Associates Dba Whitney & CO transactions in Eli Lilly & CO stock. As of the latest transaction made, W.G. Shaheen & Associates Dba Whitney & CO holds 9,166 shares of LLY stock, worth $5.87 Million. This represents 0.74% of its overall portfolio holdings.
Number of Shares
9,166
Previous 8,718
5.14%
Holding current value
$5.87 Million
Previous $7.2 Million
0.76%
% of portfolio
0.74%
Previous 0.81%
Shares
4 transactions
Others Institutions Holding LLY
# of Institutions
4,404Shares Held
807MCall Options Held
9.91MPut Options Held
10.9M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$64.9 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$61.5 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$50.8 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$42.2 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.4MShares$22.1 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $609B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...